NCT01769781View on ClinicalTrials.gov

Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Endometriosis
Interventions
DRUG

anastrazole

combined treatment with aromatase inhibitor (anastrazole) plus GnRH analog (leuprolide acetate) for three months

DRUG

GnRH analog alone

treatment for three months with GnRH analog (leuprolide acetate) alone

Trial Locations (1)

00153

Cerm-Hungaria, Rome

All Listed Sponsors
lead

Centre for Endocrinology and Reproductive Medicine, Italy

NETWORK

NCT01769781 - Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence | Biotech Hunter | Biotech Hunter